Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968110 · ClinicalTrials.gov registry record · Early Phase 1
Xolair Treatment for Milk Allergic Children
A Early Phase 1 study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT00968110: Completed Early Phase 1 study, sponsored by Boston Children's Hospital.
NCT00968110 is a Early Phase 1 study that has completed, run by Boston Children's Hospital. The registered enrollment target is 10 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00968110, a Early Phase 1 study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a pilot feasibility study, using Xolair pretreatment for oral milk desensitization. The major assessment will be safety, and the investigators will evaluate for any type of reaction, including allergic reactions that occur during the course of the study.
Interventions
- DRUG omalizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-04 |
| Phase | Early Phase 1 |
What the finished NCT00968110 record still lists
NCT00968110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which omalizumab is the first listed.
NCT00968110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00968110 about?
NCT00968110 is a clinical study titled "Xolair Treatment for Milk Allergic Children". This is a pilot feasibility study, using Xolair pretreatment for oral milk desensitization. The major assessment will be safety, and the investigators will evaluate for any type of reaction, including allergic reactions that occur during the course of the study.
What is the current status of trial NCT00968110?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2009-03. Estimated completion is 2017-04.
What interventions are being tested in trial NCT00968110?
The interventions under investigation include: omalizumab (DRUG).
Who is sponsoring clinical trial NCT00968110?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00968110's enrollment target sits among peer trials
10 1629th of 2000 higher than 256 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia